MedDataX Logo

GN Tobacco Use Survey

NCT ID: NCT00121368

Last Updated: 2013-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-02-29

Study Completion Date

2005-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Smoking can contribute to many health problems for mothers and their babies. In developing countries, there is little information about the number of pregnant women that smoke and the reasons why some pregnant women choose to smoke. The purpose of this multi-site tobacco use survey is to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Smoking is regarded as one of the few potentially preventable factors associated with low birth weight, very preterm birth and perinatal death. In an effort to determine the prevalence of tobacco use (smoking and smokeless tobacco) and to collect relevant data in support of a potential smoking prevention or cessation intervention, a multi-site tobacco use survey is being conducted in several countries. The survey will be used to obtain information on knowledge, attitudes and behaviors among pregnant women in diverse populations regarding tobacco products.

The primary outcome is tobacco use status during pregnancy. Secondary outcomes include: knowledge and attitudes regarding tobacco products, health hazards of tobacco use and environmental tobacco smoke (ETS) exposure.

Sample size of 750 per country was calculated under the assumptions that the prevalence of tobacco use could be as low as 0.05 with a coefficient of variation of approximately 15% and a prevalence of 0.10 with a CV of approximately 11%.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Global Network Maternal and child health International Women's health Tobacco Smoking Africa Latin America South America Guatemala Zambia India Argentina Democratic Republic of the Congo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women of legal consent and child-bearing age (18-45)
* Attendance at a participating clinic

Exclusion Criteria

* Pregnant women with disabilities such as deafness, serious mental illness, or mental retardation
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Global Network for Women's and Children's Health Research

OTHER

Sponsor Role collaborator

Bill and Melinda Gates Foundation

OTHER

Sponsor Role collaborator

Fogarty International Center of the National Institute of Health

NIH

Sponsor Role collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

Sponsor Role collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

Sponsor Role collaborator

RTI International

OTHER

Sponsor Role collaborator

NICHD Global Network for Women's and Children's Health

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michele Bloch, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

National Cancer Institute (NCI)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Buenos Aires, , Argentina

Site Status

Recife, , Brazil

Site Status

Quito, , Ecuador

Site Status

Guatemala City, , Guatemala

Site Status

Bhubaneswar, Odisha, India

Site Status

Belagavi, , India

Site Status

Karachi, , Pakistan

Site Status

Kinshasa, , Republic of the Congo

Site Status

Lusaka, , Zambia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina Brazil Ecuador Guatemala India Pakistan Republic of the Congo Zambia

Related Links

Access external resources that provide additional context or updates about the study.

http://gn.rti.org/

Global Network for Women's and Children's Health

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP01 Tobacco Use

Identifier Type: -

Identifier Source: org_study_id